Journal of Embryo Transfer (한국수정란이식학회지)

The Korean Society of Embryo Transfer (한국수정란이식학회)
권호 표지

Endocrine Disrupting Activities of Parabens: An Overview of Current Databases on Their Estrogenicity

  • Dang, Vu Hoang (Laboratory of Veterinary Biochemistry and Molecular Biology, College of Veterinary Medicine, Chungbuk National University) ;
  • Jeung, Eui-Bae (Laboratory of Veterinary Biochemistry and Molecular Biology, College of Veterinary Medicine, Chungbuk National University)
  • Published : 2008.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Recently, parabens have been believed to act as xenoestrogens, an identified class of endocrine disruptors (EDs). These environmental compounds are the most well-known as preservatives in many commercial products, including food, cosmetics and pharmaceutical industries. It has been demonstrated that the human health risks of parabens result from a long-term exposure to skin in which this chemical group is rapidly absorbed through the skin. On the other hand, parabens are also completely absorbed from gastrointestinal tract. It has reported that these substances possess several biological effects in which inhibitory property involved in membrane transports and mitochondrial functions is considered to be important for their action. Testing of parabens has revealed that estrogen-like activities of these chemicals are much less potent than natural estrogen, $17{\beta}$ estradiol (E2). Additionally, the estrogenicity of individual paraben- compounds is distinct depending upon their biochemical structure. Recent findings of paraben-estrogenic activities have shown that these compounds may affect breast cancer incidence in women, suggesting adverse ecological outcomes of this environmental group on human and animal health. Although the biological and toxicological effects of parabens have been demonstrated in many previous studies, possible mechanism(s) of their action are required to be explored in order to bring the better understanding in the detrimental impacts of parabens in human and wildlife. There have several different types of parabens which are the most widely used as preservatives. These include methyl-paraben, ethylparaben, propylparaben, butylparaben and p-hydroxybenzoic acid, a major metabolite of parabens. In this review, we summarize current database based on in vitro and in vivo assays for estrogenic activities and health risk assessment of paraben- EDs which have been published previously.

Keywords

References

  1. An BS, Choi KC, Kang SK, Hwang WS and Jeung EB. 2003. Novel Calbindin-D(9k) protein as a useful biomarker for environmental estrogenic compounds in the uterus of immature rats. Reprod. Toxicol. 17:311-319 https://doi.org/10.1016/S0890-6238(03)00003-0
  2. An BS, Kang SK, Shin JH and Jeung EB. 2002. Stimulation of calbindin-D(9k) mRNA expression in the rat uterus by octyl-phenol, nonylphenol and bisphenol. Mol. Cell. Endocrinol. 191:177-186 https://doi.org/10.1016/S0303-7207(02)00042-4
  3. Bando H, Mohri S, Yamashita F, Takakura Y and Hashida M. 1997. Effects of skin metabolism on percutaneous penetration of lipophilic drugs. J. Pharm. Sci. 86:759-761 https://doi.org/10.1021/js960408n
  4. Bardin A, Boulle N, Lazennec G, Vignon F and Pujol P. 2004. Loss of ERbeta expression as a common step in estrogendependent tumor progression. Endocr. Relat. Cancer. 11:537-551 https://doi.org/10.1677/erc.1.00800
  5. Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R and Sheehan DM. 2000. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands. Toxicol. Sci. 54:138-153 https://doi.org/10.1093/toxsci/54.1.138
  6. Bolger R, Wiese TE, Ervin K, Nestich S and Checovich W. 1998. Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environ. Health. Perspect. 106:551-557 https://doi.org/10.2307/3434229
  7. Bulger WH, Muccitelli RM and Kupfer D. 1978. Interactions of methoxychlor, methoxychlor base-soluble contaminant, and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane with rat uterine estrogen receptor. J. Toxicol. Environ. Health. 4:881-893 https://doi.org/10.1080/15287397809529709
  8. Byford JR, Shaw LE, Drew MG, Pope GS, Sauer MJ and Darbre PD. 2002. Oestrogenic activity of parabens in MCF7 human breast cancer cells. J. Steroid. Biochem. Mol. Biol. 80:49-60 https://doi.org/10.1016/S0960-0760(01)00174-1
  9. Certa H, Fedtke N, Wiegand HJ, Muller AM and Bolt HM. 1996. Toxicokinetics of p-tert-octylphenol in male Wistar rats. Arch. Toxicol. 71:112-122 https://doi.org/10.1007/s002040050365
  10. Choi KC and Jeung EB. 2003. The biomarker and endocrine disruptors in mammals. In J. Reprod. Dev. 49:337-345 https://doi.org/10.1262/jrd.49.337
  11. Choi SM and Lee BM. 2004. An alternative mode of action of endocrine-disrupting chemicals and chemoprevention. J. Toxicol. Environ. Health. B. Crit. Rev. 7:451-463 https://doi.org/10.1080/10937400490512500
  12. Cupp AS and Skinner MK. 2001. Actions of the endocrine disruptor methoxychlor and its estrogenic metabolite on in vitro embryonic rat seminiferous cord formation and perinatal testis growth. Reprod. Toxicol. 15:317-326 https://doi.org/10.1016/S0890-6238(01)00124-1
  13. Dang VH, Choi KC and Jeung EB. 2007c. Tetrabromodiphenyl ether (BDE 47) evokes estrogenicity and calbindin-D9k expression through an estrogen receptor-mediated pathway in the uterus of immature rats. Toxicol. Sci. 97:504- 511 https://doi.org/10.1093/toxsci/kfm051
  14. Dang VH, Choi KC, Hyun SH and Jeung EB. 2007a. Analysis of gene expression profiles in the offspring of rats following maternal exposure to xenoestrogens. Reprod. Toxicol. 23:42-54 https://doi.org/10.1016/j.reprotox.2006.08.010
  15. Dang VH, Choi KC, Hyun SH and Jeung EB. 2007b. Induction of uterine calbindin-d9k through an estrogen receptordependent pathway following single injection with xenobiotic agents in immature rats. J. Toxicol. Environ. Health. A. 70:171-182 https://doi.org/10.1080/15287390600755257
  16. Dang VH, Nguyen TH, Choi KC and Jeung EB. 2007d. A calcium-binding protein, calbindin-D9k, is regulated through an estrogen-receptor-mediated mechanism following xenoestrogen exposure in the GH3 cell line. Toxicol. Sci. 98: 408-415 https://doi.org/10.1093/toxsci/kfm120
  17. Dang VH, Nguyen TH, Choi KC and Jeung EB. 2007e. Unexpected estrogenicity of endocrine disruptors may evoke a failure of pregnancy derived from uterine function: Overview of their possible mechanism(s) through steroid receptors. J. Emb. Trans. 22:199-208
  18. Danzo BJ. 1997. Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. Environ. Health. Perspect. 105:294-301 https://doi.org/10.2307/3433266
  19. Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ and Pope GS. 2004. Concentrations of parabens in human breast tumours. J. Appl. Toxicol. 24:5-13 https://doi.org/10.1002/jat.958
  20. Darbre PD, Byford JR, Shaw LE, Hall S, Coldham NG, Pope GS and Sauer MJ. 2003. Oestrogenic activity of benzylparaben. J. Appl. Toxicol. 23:43-51 https://doi.org/10.1002/jat.886
  21. Darbre PD, Byford JR, Shaw LE, Horton RA, Pope GS and Sauer MJ. 2002. Oestrogenic activity of isobutylparaben in vitro and in vivo. J. Appl. Toxicol. 22:219-226 https://doi.org/10.1002/jat.860
  22. Daston GP. 2004. Developmental toxicity evaluation of butylparaben in Sprague-Dawley rats. Birth. Defects. Res. B. Dev. Reprod. Toxicol. 71: 96-302
  23. DeRosa C, Richter P, Pohl H and Jones DE. 1998. Environmental exposures that affect the endocrine system: public health implications. J. Toxicol. Environ. Health. B. Crit.Rev. 1:3-26 https://doi.org/10.1080/10937409809524541
  24. Elsby R, Maggs JL, Ashby J and Park BK. 2001a. Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J. Pharmacol. Exp. Ther. 297:103-113
  25. Elsby R, Maggs JL, Ashby J, Paton D, Sumpter JP and Park BK. 2001b. Assessment of the effects of metabolism on the estrogenic activity of xenoestrogens: a two-stage approach coupling human liver microsomes and a yeast estrogenicity assay. J. Pharmacol. Exp. Ther. 296:329-337
  26. Gaido KW, Leonard LS, Lovell S, Gould JC, Babai D, Portier CJ and McDonnell DP. 1997. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143:205-212 https://doi.org/10.1006/taap.1996.8069
  27. Gardner RM, Verner G, Kirkland JL and Stancel GM. 1989. Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat and during the estrous cycle. J. Steroid. Biochem. 32:339-343 https://doi.org/10.1016/0022-4731(89)90205-7
  28. Golden R, Gandy J and Vollmer G. 2005. A review of the endocrine activity of parabens and implications for potential risks to human health. Crit. Rev. Toxicol. 35:435-458 https://doi.org/10.1080/10408440490920104
  29. Gould JC, Leonard LS, Maness SC, Wagner BL, Conner K, Zacharewski T, Safe S, McDonnell DP and Gaido KW. 1998. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol. Cell. Endocrinol. 142:203-214 https://doi.org/10.1016/S0303-7207(98)00084-7
  30. Gray LE Jr, Kelce WR, Wiese T, Tyl R, Gaido K, Cook J, Klinefelter G, Desaulniers D, Wilson E, Zacharewski T, Waller C, Foster P, Laskey J, Reel J, Giesy J, Laws S, Mc- Lachlan J, Breslin W, Cooper R, Di Giulio R, Johnson R, Purdy R, Mihaich E, Safe S, Colborn T and et al. 1997. Endocrine screening methods workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod. Toxicol. 11:719-750 https://doi.org/10.1016/S0890-6238(97)00025-7
  31. Gruvberger B, Bruze M and Tammela M. 1998. Preservatives in moisturizers on the Swedish market. Acta. Derm. Venereol. 78: 52-56 https://doi.org/10.1080/00015559850135850
  32. Harvey PW and Darbre P. 2004. Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? J. Appl. Toxicol. 24:167-176 https://doi.org/10.1002/jat.978
  33. Heppell SA, Denslow ND, Folmar LC and Sullivan CV. 1995. Universal assay of vitellogenin as a biomarker for environmental estrogens. Environ. Health. Perspect. 103 Suppl 7: 9-15
  34. Hong EJ, Choi KC and Jeung EB. 2003. Maternal-fetal transfer of endocrine disruptors in the induction of calbindin- D9k mRNA and protein during pregnancy in rat model. Mol. Cell. Endocrinol. 212:63-72 https://doi.org/10.1016/j.mce.2003.08.011
  35. Hong EJ, Choi KC and Jeung EB. 2004a. Induction of calbindin- D9k messenger RNA and protein by maternal exposure to alkylphenols during late pregnancy in maternal and neonatal uteri of rats. Biol. Reprod. 71:669-675 https://doi.org/10.1095/biolreprod.103.026146
  36. Hong EJ, Choi KC and Jeung EB. 2005. Maternal exposure to bisphenol a during late pregnancy resulted in an increase of calbindin-D9k mRNA and protein in maternal and postnatal rat uteri. J. Reprod. Dev. 51:499-508 https://doi.org/10.1262/jrd.17012
  37. Hong EJ, Choi KC, Jung YW, Leung PC and Jeung EB. 2004b. Transfer of maternally injected endocrine disruptors through breast milk during lactation induces neonatal calbindin-D9k in the rat model. Reprod. Toxicol. 18:661-668 https://doi.org/10.1016/j.reprotox.2004.03.005
  38. Hossaini A, Larsen JJ and Larsen JC. 2000. Lack of oestrogenic effects of food preservatives (parabens) in uterotrophic assays. Food. Chem. Toxicol. 38:319-323 https://doi.org/10.1016/S0278-6915(99)00160-X
  39. Jones RC and Edgren RA. 1973. The effects of various steroids on the vaginal histology in the rat. Fertil. Steril. 24: 284-291 https://doi.org/10.1016/S0015-0282(16)39613-3
  40. Laws SC, Carey SA, Ferrell JM, Bodman GJ and Cooper RL. 2000. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol. Sci. 54:154-167 https://doi.org/10.1093/toxsci/54.1.154
  41. Lemini C, Silva G, Timossi C, Luque D, Valverde A, Gonzalez- Martinez M, Hernandez A, Rubio-Poo C, Chavez Lara B and Valenzuela F. 1997. Estrogenic effects of p-hydroxybenzoic acid in CD1 mice. Environ. Res. 75:130-134 https://doi.org/10.1006/enrs.1997.3782
  42. Lobemeier C, Tschoetschel C, Westie S and Heymann E. 1996. Hydrolysis of parabenes by extracts from differing layers of human skin. Biol. Chem. 377:647-651
  43. McKinney JD and Waller CL. 1998. Molecular determinants of hormone mimicry: halogenated aromatic hydrocarbon environmental agents. J. Toxicol. Environ. Health. B. Crit. Rev. 1:27-58 https://doi.org/10.1080/10937409809524542
  44. McLachlan JA, Simpson E and Martin M. 2006. Endocrine disrupters and female reproductive health. Best. Pract. Res. Clin. Endocrinol. Metab. 20:63-75 https://doi.org/10.1016/j.beem.2005.09.009
  45. Moggs JG. 2005. Molecular responses to xenoestrogens: mechanistic insights from toxicogenomics. Toxicology 213: 177-193 https://doi.org/10.1016/j.tox.2005.05.020
  46. Mukku VR and Stancel GM. 1985. Regulation of epidermal growth factor receptor by estrogen. J. Biol. Chem. 260: 9820-9824
  47. Nelson KG, Takahashi T, Bossert NL, Walmer DK and McLachlan JA. 1991. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc. Natl. Acad. Sci. USA. 88:21-25.
  48. Newbold RR, Jefferson WN, Padilla-Banks E and Haseman J. 2004. Developmental exposure to diethylstilbestrol (DES) alters uterine response to estrogens in prepubescent mice: low versus high dose effects. Reprod. Toxicol. 18:399-406 https://doi.org/10.1016/j.reprotox.2004.01.007
  49. Okubo T, Yokoyama Y, Kano K and Kano I. 2001. ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR. Food. Chem. Toxicol. 39:1225-1232 https://doi.org/10.1016/S0278-6915(01)00073-4
  50. Owens JW and Ashby J. 2002. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development. Crit. Rev. Toxicol. 32:445-520 https://doi.org/10.1080/20024091064291
  51. Pedersen KL, Pedersen SN, Christiansen LB, Korsgaard B and Bjerregaard P. 2000. The preservatives ethyl-, propyl- and butylparaben are oestrogenic in an in vivo fish assay. Pharmacol. Toxicol. 86:110-113 https://doi.org/10.1034/j.1600-0773.2000.d01-20.x
  52. Prusakiewicz JJ, Harville HM, Zhang Y, Ackermann C and Voorman RL. 2007. Parabens inhibit human skin estrogen sulfotransferase activity: possible link to paraben estrogenic effects. Toxicology 232:248-256 https://doi.org/10.1016/j.tox.2007.01.010
  53. Rastogi SC, Schouten A, de Kruijf N and Weijland JW. 1995. Contents of methyl-, ethyl-, propyl-, butyl- and benzylparaben in cosmetic products. Contact. Dermatitis. 32:28-30 https://doi.org/10.1111/j.1600-0536.1995.tb00836.x
  54. Ren L, Marquardt MA and Lech JJ. 1997. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7. Chem. Biol. Interact. 104:55-64 https://doi.org/10.1016/S0009-2797(97)03767-8
  55. Riggs BL and Hartmann LC. 2003. Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice. N. Engl. J. Med. 348:618-629 https://doi.org/10.1056/NEJMra022219
  56. Routledge EJ, Parker J, Odum J, Ashby J and Sumpter JP. 1998. Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol. Appl. Pharmacol. 153:12-19 https://doi.org/10.1006/taap.1998.8544
  57. Roy D, Palangat M, Chen CW, Thomas RD, Colerangle J, Atkinson A and Yan ZJ. 1997. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. J. Toxicol. Environ. Health. 50:1-29 https://doi.org/10.1080/009841097160573
  58. Soni MG, Burdock GA, Taylor SL and Greenberg NA. 2001. Safety assessment of propyl paraben: a review of the published literature. Food. Chem. Toxicol. 39:513-532 https://doi.org/10.1016/S0278-6915(00)00162-9
  59. Soni MG, Taylor SL, Greenberg NA and Burdock GA. 2002. Evaluation of the health aspects of methyl paraben: a review of the published literature. Food. Chem. Tox[icol. 40: 1335-1373 https://doi.org/10.1016/S0278-6915(02)00107-2
  60. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N and Serrano FO. 1995. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health. Perspect. 103 Suppl 7:113-122 https://doi.org/10.2307/3428004
  61. Stellman SD, Djordjevic MV, Muscat JE, Gong L, Bernstein D, Citron ML, White A, Kemeny M, Busch E and Nafziger AN. 1998. Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York. Cancer. Epidemiol. Biomarkers. Prev. 7:489-496
  62. Turusov V, Rakitsky V and Tomatis L. 2002. Dichlorodiphenyltrichloroethane (DDT): ubiquity, persistence, and risks. Environ. Health. Perspect. 110:125-128 https://doi.org/10.1289/ehp.02110125
  63. Upmeier A, Degen GH, Schuhmacher US, Certa H and Bolt HM. 1999. Toxicokinetics of p-tert-octylphenol in female DA/Han rats after single i.v. and oral application. Arch. Toxicol. 73: 217-222 https://doi.org/10.1007/s002040050609
  64. Watanabe H, Suzuki A, Kobayashi M, Takahashi E, Itamoto M, Lubahn DB, Handa H and Iguchi T. 2003. Analysis of temporal changes in the expression of estrogen-regulated genes in the uterus. J. Mol. Endocrinol. 30:347-358 https://doi.org/10.1677/jme.0.0300347
  65. Wilson ME, Price RH, Jr and Handa RJ. 1998. Estrogen receptor- beta messenger ribonucleic acid expression in the pituitary gland. Endocrinology 139: 5151-5156 https://doi.org/10.1210/en.139.12.5151